European Archives - Page 749 of 1095 - European Medical Journal

The Role of PARP Inhibitors in Ovarian Cancer: An Emerging Picture

Dr Birrer presented on the current landscape of platinum-sensitive recurrent ovarian cancer (PSR OC), including USA and European treatment guidelines.

FutureNova wins prestigious Plastics Industry Award

Chelmsford based FutureNova is celebrating having won Consumer product Design of the Year at the prestigious Plastics Industry Award for its innovative…

Positive Impact of Patient Prehabilitation for Surgery

A study has shown that prehabilitation, a structured exercise and nutrition conditioning programme prior to operation, leads to an improvement in…

Laparoscopic Pancreatoduodenectomy Shortens Hospital Stay Compared with Open Pancreatoduodenectomy

Laparoscopic pancreatoduodenectomy (LPD) has been shown by the results of the PADULAP trial, which was conducted from 2013–2017, to lead to both shorter…

This September 2018, EMJ Supports…

This September, EMJ proudly showcases its support for World Alzheimer’s Month and National Doodle Day.

Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time

Transjugular intrahepatic portosystemic shunt. Portal hypertension is the main complication of cirrhosis and occurs due to increased pressure within the…

EMJ Hepatology 6 [Suppl 2] 2018

Transjugular intrahepatic portosystemic shunt (TIPS) offers an effective treatment for patients with complications of portal hypertension, specifically…

Roundtable: a moment with the millennial doctors

A roundtable discussion with two millennial doctors to find out what they want from pharma, both in terms of digital content, rep interactions and more.

Leo Pharma’s Gitte Aabo on the power of patient centricity

Gitte Aabo, President and CEO, LEO Pharma A/S, speaks about LEO’s leading position in dermatology and life-changing moments which help foster the patient-centric environment and mindset that is embedded so deeply within the company.

Roundtable: the singular best move for medical affairs

How can medical affairs teams construct a game plan to make sure they are prepared for the changing landscape within big data?